7:15 PM
 | 
Jul 31, 2007
 |  BC Extra  |  Politics & Policy

EMEA adding recombinant Factor VIII warning

EMEA said it will add a warning of neutralizing antibodies to the summary of product characteristics for all recombinant Factor VIII (rFVIII) products marketed in the EU for hemophilia A. The warning follows an agency review of...

Read the full 163 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >